Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

387
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
387
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

219
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
219
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

244
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
244
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

188
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

287
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
287

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanoreceptor plexin D1 regulates lymphatic valve morphogenesis and lymphedema pathogenesis.

The Journal of clinical investigation·2026
Same author

Exclusion of CLIC5 as a Candidate Gene and Identification of NEFM as a Possible Novel Gene Correlated With Autosomal Recessive Pure Cerebellar Ataxia in a Highly Consanguineous Family.

Molecular genetics & genomic medicine·2026
Same author

Assessing breast MRI image quality: the bMRI-QUAL scoring system.

European radiology·2026
Same author

Inner Retina Changes in ABCA4-Related Retinopathy: Structure-Function Relationship.

Investigative ophthalmology & visual science·2025
Same author

Identification of Specific microRNAs in Adipose Tissue Affected by Lipedema.

Current issues in molecular biology·2024
Same author

Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis.

Archives of dermatological research·2024

Related Experiment Video

Updated: Aug 18, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Dietary supplements for intestinal inflammation.

Aysha Karim Kiani1, Gabriele Bonetti2, Kevin Donato1

  • 1MAGI Euregio, Bolzano, Italy.

Journal of Preventive Medicine and Hygiene
|December 8, 2022
PubMed
Summary

Dietary supplements can help manage inflammatory bowel disease (IBD) by stabilizing gut microbiota and strengthening the intestinal barrier. They offer an alternative to drugs, reducing side effects and improving remission rates for IBD patients.

Keywords:
Dietary supplementsDysbiosisInflammatory bowel diseaseIntestinal inflammationMediterranean diet

More Related Videos

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.5K

Related Experiment Videos

Last Updated: Aug 18, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

47.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.5K

Area of Science:

  • Gastroenterology
  • Nutrition Science
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal inflammation with symptoms like pain, diarrhea, and weight loss.
  • Drug resistance and low remission rates (<50%) highlight the need for alternative IBD management strategies.
  • Diet significantly influences gut inflammation, with unbalanced diets promoting dysbiosis and immune dysregulation.

Purpose of the Study:

  • To explore the role of dietary supplements in managing inflammatory bowel disease (IBD).
  • To investigate how supplements can improve gut microbiota stability and mucosal barrier function.
  • To present supplements as a complementary approach to conventional IBD therapies.

Main Methods:

  • Review of existing literature on diet, gut microbiota, and IBD.
  • Identification of specific anti-inflammatory dietary supplements (probiotics, omega-3s, etc.).
  • Analysis of the mechanisms by which supplements impact intestinal inflammation and microbial balance.

Main Results:

  • The Mediterranean Diet demonstrates anti-inflammatory properties and aids in preventing dysbiosis.
  • Specific supplements like probiotics, butyrate, and omega-3 fatty acids support gut barrier integrity.
  • These supplements help stabilize the intestinal microbial community, potentially preventing or alleviating IBD symptoms.

Conclusions:

  • Integrating anti-inflammatory dietary supplements into patient diets is recommended for IBD management.
  • Supplements can enhance treatment efficacy, reduce drug-related costs and side effects, and combat recurrent relapses.
  • Dietary interventions, including supplements, are crucial for maintaining gut health and improving IBD patient outcomes.